Home Compare ABT vs DEMANT.CO
Stock Comparison · Industry comparison · Medical Devices

Abbott Laboratories vs Demant A/S: Which Stock Looks Stronger in 2026?

Abbott Laboratories holds the cleaner structural position, with the lead spread across stability and profitability. Demant A/S still leads on growth and valuation, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The result is anchored in stability, but profitability also reinforces the same direction. The overall score gap is 12 points in favour of Abbott Laboratories.

INDUSTRY COMPARISON

Both operate in: Medical Devices

This comparison is based on industry proximity, not on functional trajectory similarity. ABT and DEMANT.CO share the same industry classification.

For a similarity-based comparison, see how Abbott Laboratories and Demant A/S each position within their functional peer groups in AssetNext.

Peer-Relative Score
ABT
Abbott Laboratories
53
Peer-Score
Signal qualityHigh
vs
DEMANT.CO
Demant A/S
41
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: ABT vs DEMANT.CO Profitability 59 34 Stability 80 28 Valuation 66 78 Growth 0 10 ABT DEMANT.CO
Gap Ranking
#1 Stability +52
#2 Profitability +25
#3 Valuation +12
#4 Growth +10
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for ABT and DEMANT.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer ABTDEMANT.CO Relative valuation Structural strength

Abbott Laboratories looks stronger, but the price setup still looks more supportive for Demant A/S.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
On stability, Abbott Laboratories ranks near the top of the group; Demant A/S sits in the weaker half.
Profitability
On profitability, Abbott Laboratories is positioned higher in the group, while Demant A/S is closer to the middle.
Stability — Dominant Gap
ABT
80
DEMANT.CO
28
Gap+52in favour of ABT

The stability gap is very wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Demant A/S, with a forward P/E that is 3.6 turns lower there.

What this means for the comparison

The lead is built on both stability and profitability — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the ABT vs DEMANT.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-driven comparisons

Explore how ABT and DEMANT.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.